Skip to content

Thrombus Analysis of Ischemic Stroke

Thrombus Analysis of Ischemic Stroke

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07043413
Acronym
TAOIST
Enrollment
500
Registered
2025-06-29
Start date
2022-01-25
Completion date
2029-12-31
Last updated
2025-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Infarction

Keywords

cerebral infarction, thrombus, stroke mechanism, prognosis

Brief summary

Patients with acute ischemic stroke who have undergone endovascular thrombectomy will be eligible to be included, and thrombus will be collected after obtaining informed consent. Enrolled patients will receive a comprehensive diagnostic evaluation and the best medical treatment according to recent stroke management guidelines. The mechanism of the stroke will be classified into atherosclerotic, cardiac embolism, others and unknown causes based on diagnostic workup. Patients will be monitored in an outpatient clinic for vascular events including stroke recurrence, death, and bleeding events, which will continue for up to two years after the initial stroke event. Thrombus information related to RNA expression patterns and histological characteristics will be analyzed to classify the stroke mechanism and predict future vascular events after the initial stroke.

Interventions

DIAGNOSTIC_TESTthrombus analysis

Detailed expression pattern of RNA and histological characteristics will be investigated.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients with acute ischemic stroke who had undergone endovascular thrombectomy

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Vascular eventstwo years after initial strokemajor vascular events after endovascular thrombectomy, including stroke, myocardial infarction, and vascular death

Secondary

MeasureTime frameDescription
Thromboembolic eventstwo years after initial strokeAny thromboembolic events after endovascular thrombectomy including ischemic stroke, transient ischemic attack, myocardial infarction or unstable angina, peripheral artery disease requiring hospitalization, venous thromboembolism, pulmonary embolism and vascular death

Other

MeasureTime frameDescription
overall mortalitytwo years after initial strokeany death event after endovascular thrombectomy

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026